Clinical trial
ProspectIve, MuLti-Center Study to EvaLUate TreatMent of Subjects With OcclusivE Disease With a Novel PAcliTazel-CoatEd Angioplasty Balloon in Below-The-Knee (BTK) Arteries: a Post Market Clinical Study
NCT03395236 is registered in ClinicalTrials.gov with Spectranetics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ProspectIve, MuLti-Center Study to EvaLUate TreatMent of Subjects With OcclusivE Disease With a Novel PAcliTazel-CoatEd Angioplasty Balloon in Below-The-Knee (BTK) Arteries: a Post Market Clinical Study
- Lead sponsor
- Spectranetics Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 20, 2018
- Completion date
- August 23, 2023
- Enrollment
- 49 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.